Company intelligence / Profile preview

RxMD Solutions

New Jersey, USA

Ownership: Private
Development stage: Other

Overview

RxMD is a consulting firm rather than a drug developer. They have supported development of approved assets in flu, HCV, HIV, HBV, erectile dysfunction, and cell therapy. They have also provided consulting on programs that were not successfully taken to approval.

Therapeutic areas: HematologyImmunologyNephrologyNeurologyDermatologyInfectious DiseasesRheumatologyRare DiseasesPulmonologyMen's HealthOphthalmology
Modalities: Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugateCell therapyGene therapyCAR-T cell therapy
Industry: Consulting

Partnerships

Worked with U.S. and EU-based big pharma and biotech companies including Novartis

Beyond the preview

Go deeper on RxMD Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxMD Solutions.

Explore the full profile